Qure Biotechnology (Shanghai) Co., Ltd.
PrivateLast Round
Series C
Extension
Jun 5, 2025
Total Funding Raised
$46.9M
Company Overview
Qure Biotechnology (Shanghai) Co., Ltd. is a biopharmaceutical company that develops bispecific and multispecific antibody and protein therapeutics for the treatment of cancer, autoimmune diseases, and inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qure Biotechnology (Shanghai) Co., Ltd. Comparables
Compare Qure Biotechnology (Shanghai) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpimAb Biotherapeutics | 86% | |
| Elpiscience Biopharmaceuticals | 81% | |
| Merus N.V. | 78% |
Qure Biotechnology (Shanghai) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jun 5, 2025 | ||||
| Series B | Dec 23, 2021 | ||||
| VC Round | Jul 29, 2020 | ||||
| Series A Extension | Apr 10, 2020 | ||||
| Series A | Aug 12, 2019 | ||||
Angel | May 1, 2017 |
Qure Biotechnology (Shanghai) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longmen Capital | Series B |
| Oriza Holdings | Series B |
| Shanghai Zhangjiang Torch Venture Capital | Series B |
| Viva BioInnovator | Angel |
| Guoshun Investment | Series B |
| BOCOM International Holdings Company Limited | Series B |
| Efung Capital | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2025
$14M round led by Efeng Capital.
- Jul 29, 2020
Completed a VC Round funding round.
Qure Biotechnology (Shanghai) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Qure Biotechnology (Shanghai) Co., Ltd.'s valuation, stock price, and market status.
Is Qure Biotechnology (Shanghai) Co., Ltd. a public or private company?
Qure Biotechnology (Shanghai) Co., Ltd. is a private company.
What is the current stock price of Qure Biotechnology (Shanghai) Co., Ltd.?
Qure Biotechnology (Shanghai) Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Qure Biotechnology (Shanghai) Co., Ltd. worth (valuation)?
Valuation information for Qure Biotechnology (Shanghai) Co., Ltd. is not publicly available.
Can I buy Qure Biotechnology (Shanghai) Co., Ltd. stock?
Qure Biotechnology (Shanghai) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Qure Biotechnology (Shanghai) Co., Ltd.'s last funding round?
Qure Biotechnology (Shanghai) Co., Ltd.'s most recent funding round was Series C on June 5, 2025.
Who are the main investors in Qure Biotechnology (Shanghai) Co., Ltd.?
Key investors in Qure Biotechnology (Shanghai) Co., Ltd. include BOCOM International Holdings Company Limited, Efung Capital, Shenzhen Capital Group.
Will Qure Biotechnology (Shanghai) Co., Ltd. IPO soon?
No public IPO plans have been announced for Qure Biotechnology (Shanghai) Co., Ltd..
How can I track Qure Biotechnology (Shanghai) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Qure Biotechnology (Shanghai) Co., Ltd.'s secondary market activity and sign up for updates.